Pacific Biosciences of California, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PACB research report →
About the company
Pacific Biosciences of California, Inc. (PACB) specializes in pioneering and manufacturing advanced genetic sequencing platforms, empowering researchers and institutions to unravel intricate genetic challenges. At the heart of its offerings are the proprietary PacBio Sequencing Systems, designed for executing, monitoring, and interpreting biochemical sequencing reactions.
- CEO
- Christian O. Henry
- IPO
- 2010
- Employees
- 575
- HQ
- Menlo Park, CA, US
Price Chart
- Market Cap
- $521.81M
- P/E
- -3.91
- P/S
- 3.26
- P/B
- 217.15
- EV/EBITDA
- -10.97
- Div Yield
- 0.00%
- Gross Margin
- 37.08%
- Op Margin
- -101.72%
- Net Margin
- -80.34%
- ROE
- -488.45%
- ROIC
- -22.69%
- Revenue
- $160.00M · 3.89%
- Net Income
- $-546,376,000 · -76.34%
- EPS
- $-1.82 · -61.06%
- Op Income
- $-557,561,000
- FCF YoY
- 46.33%
- 52W High
- $2.73
- 52W Low
- $1.09
- 50D MA
- $1.45
- 200D MA
- $1.70
- Beta
- 2.29
- Avg Volume
- 6.28M
Get TickerSpark's AI analysis on PACB
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 3, 26 | MOHR MARSHALL | other | 223,492 |
| Jun 3, 26 | Gibson Christopher | other | 74,497 |
| Jun 3, 26 | Smith Christopher M | other | 223,492 |
| Jun 3, 26 | Valantine Hannah | other | 223,492 |
| Jun 3, 26 | LIVINGSTON RANDALL S | other | 223,492 |
| Jun 3, 26 | Ericson William W. | other | 223,492 |
| Jun 3, 26 | MILLIGAN JOHN F | other | 223,492 |
| Jun 3, 26 | ORDONEZ KATHY | other | 223,492 |
| Apr 8, 26 | Gibson Christopher | other | 57,473 |
| Apr 8, 26 | Gibson Christopher | other | 77,842 |
Our PACB coverage
Recent articles, reports, and earnings notes.
No research on PACB yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PACB report →Similar companies
Peers in the same neighborhood.